Acceptability of adding a non-contrast abdominal CT scan to screen for kidney cancer and other abdominal pathology within a community-based CT screening programme for lung cancer: A qualitative study
- PMID: 38950010
- PMCID: PMC11216619
- DOI: 10.1371/journal.pone.0300313
Acceptability of adding a non-contrast abdominal CT scan to screen for kidney cancer and other abdominal pathology within a community-based CT screening programme for lung cancer: A qualitative study
Abstract
Objectives: The Yorkshire Kidney Screening Trial (YKST) is a feasibility study of adding non-contrast abdominal CT scanning to screen for kidney cancer and other abdominal malignancies to community-based CT screening for lung cancer within the Yorkshire Lung Screening Trial (YLST). This study explored the acceptability of the combined screening approach to participants and healthcare professionals (HCPs) involved in the trial.
Methods: We conducted semi-structured interviews with eight HCPs and 25 participants returning for the second round of scanning within YLST, 20 who had taken up the offer of the additional abdominal CT scan and five who had declined. Transcripts were analysed using thematic analysis, guided by the Theoretical Framework of Acceptability.
Results: Overall, combining the offer of a non-contrast abdominal CT scan alongside the low-dose thoracic CT was considered acceptable to participants, including those who had declined the abdominal scan. The offer of the additional scan made sense and fitted well within the process, and participants could see benefits in terms of efficiency, cost and convenience both for themselves as individuals and also more widely for the NHS. Almost all participants made an instant decision at the point of initial invitation based more on trust and emotions than the information provided. Despite this, there was a clear desire for more time to decide whether to accept the scan or not. HCPs also raised concerns about the burden on the study team and wider healthcare system arising from additional workload both within the screening process and downstream following findings on the abdominal CT scan.
Conclusions: Adding a non-contrast abdominal CT scan to community-based CT screening for lung cancer is acceptable to both participants and healthcare professionals. Giving potential participants prior notice and having clear pathways for downstream management of findings will be important if it is to be offered more widely.
Copyright: © 2024 Usher-Smith et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
GDS has received educational grants from Pfizer, AstraZeneca, and Intuitive Surgical; consultancy fees from Pfizer, BMS, Merck, EUSA Pharma, and CMR Surgical; travel expenses from Pfizer; and speaker fees from Pfizer. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Similar articles
-
The Yorkshire Kidney Screening Trial (YKST): protocol for a feasibility study of adding non-contrast abdominal CT scanning to screen for kidney cancer and other abdominal pathology within a trial of community-based CT screening for lung cancer.BMJ Open. 2022 Sep 20;12(9):e063018. doi: 10.1136/bmjopen-2022-063018. BMJ Open. 2022. PMID: 36127097 Free PMC article.
-
Short-term psychosocial outcomes of adding a non-contrast abdominal computed tomography (CT) scan to the thoracic CT within lung cancer screening.BJU Int. 2024 May;133(5):539-547. doi: 10.1111/bju.16260. Epub 2024 Jan 5. BJU Int. 2024. PMID: 38097529
-
Abdominal Noncontrast Computed Tomography Scanning to Screen for Kidney Cancer and Other Abdominal Pathology Within Community-based Computed Tomography Screening for Lung Cancer: Results of the Yorkshire Kidney Screening Trial.Eur Urol. 2025 May;87(5):561-570. doi: 10.1016/j.eururo.2024.08.029. Epub 2024 Sep 12. Eur Urol. 2025. PMID: 39271419 Clinical Trial.
-
Lung Cancer Screening in the Community Setting.Ann Thorac Surg. 2018 Jun;105(6):1627-1632. doi: 10.1016/j.athoracsur.2018.01.075. Epub 2018 Mar 1. Ann Thorac Surg. 2018. PMID: 29501646 Review.
-
Tools to Promote Shared Decision-Making in Lung Cancer Screening Using Low-Dose CT Scanning: A Systematic Review.Chest. 2020 Dec;158(6):2646-2657. doi: 10.1016/j.chest.2020.05.610. Epub 2020 Jul 3. Chest. 2020. PMID: 32629037 Free PMC article.
References
-
- Vasudev NS, Wilson M, Stewart GD, Adeyoju A, Cartledge J, Kimuli M, et al.. Challenges of early renal cancer detection: Symptom patterns and incidental diagnosis rate in a multicentre prospective UK cohort of patients presenting with suspected renal cancer. BMJ Open. 2020;10: 1–9. doi: 10.1136/bmjopen-2019-035938 - DOI - PMC - PubMed
-
- Kidney cancer statistics | Cancer Research UK. [cited 30 May 2019]. Available: https://www.cancerresearchuk.org/health-professional/cancer-statistics/s...